{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:20:57Z","timestamp":1793254857457,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bone.2025.117494","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:13:54Z","timestamp":1745410434000},"page":"117494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Oral versus intravenous antibiotics for bone and joint infections: Systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"196","author":[{"given":"Jo\u00e3o P.C.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kau\u00ea A.","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas B.P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno S.B.","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via M.R.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bone.2025.117494_bb0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2106\/JBJS.N.01350","article-title":"Trends in the epidemiology of osteomyelitis","volume":"97","author":"Kremers","year":"2015","journal-title":"J. Bone Joint Surg. [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2025.117494_bb0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0002-9343(85)90386-9","article-title":"Risk factors for osteomyelitis","volume":"78","author":"Wald","year":"1985","journal-title":"Am. J. Med. [Internet]"},{"issue":"9431","key":"10.1016\/j.bone.2025.117494_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"The Lancet [Internet]."},{"key":"10.1016\/j.bone.2025.117494_bb0020","article-title":"An update on recent progress of the epidemiology, etiology, diagnosis, and treatment of acute septic arthritis: a review","volume":"13","author":"He","year":"2023","journal-title":"Front. Cell. Infect. Microbiol. [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2025.117494_bb0025","article-title":"Chronic osteomyelitis increases long-term mortality risk in the elderly: a nationwide population-based cohort study","volume":"16","author":"Huang","year":"2016","journal-title":"BMC Geriatrics [Internet]"},{"issue":"23","key":"10.1016\/j.bone.2025.117494_bb0030","first-page":"S1","article-title":"The economic significance of orthopaedic infections","author":"Hackett","year":"2015","journal-title":"J. Am. Acad. Orthop. Surg. [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2025.117494_bb0035","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin. Infect. Dis. [Internet]"},{"issue":"5","key":"10.1016\/j.bone.2025.117494_bb0040","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2106\/JBJS.16.00240","article-title":"Global forum: the burden of bone and joint infections","volume":"99","author":"Malizos","year":"2017","journal-title":"J. Bone Joint Surg. [Internet]"},{"issue":"4","key":"10.1016\/j.bone.2025.117494_bb0045","article-title":"Fluoroquinolone-related adverse events resulting in health service use and costs: a systematic review","volume":"14","author":"Kuula","year":"2019","journal-title":"PLoS ONE [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int. J. Infect. Dis. [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2025.117494_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2011","journal-title":"Clin. Infect. Dis. [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0060","article-title":"Oral vs intravenous antibiotics for fracture-related infections","author":"(METRC) Obremskey WT","year":"2025","journal-title":"JAMA Surg. [Internet]"},{"issue":"9","key":"10.1016\/j.bone.2025.117494_bb0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S2352-4642(24)00133-0","article-title":"Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark","volume":"8","author":"Nielsen","year":"2024","journal-title":"The Lancet Child Adolesc. Health [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2025.117494_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjmed.2021.10.007","article-title":"Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review","volume":"135","author":"Wald-Dickler","year":"2021","journal-title":"Am. J. Med. [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0075","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0080","author":"Higgins"},{"key":"10.1016\/j.bone.2025.117494_bb0090","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0095","author":"McMaster University and Evidence Prime"},{"issue":"6","key":"10.1016\/j.bone.2025.117494_bb0100","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/AAC.01504-08","article-title":"Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob. Agents Chemother. [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2025.117494_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.34.1.40","article-title":"Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis","volume":"34","author":"Gentry","year":"1990","journal-title":"Antimicrob. Agents Chemother. [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2025.117494_bb0110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/AAC.35.3.538","article-title":"Ofloxacin versus parenteral therapy for chronic osteomyelitis","volume":"35","author":"Gentry","year":"1991","journal-title":"Antimicrob. Agents Chemother. [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2025.117494_bb0115","first-page":"244","article-title":"Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis","volume":"12","author":"Gomis","year":"1999","journal-title":"Revista Espa\u00f1ola De Quimioterapia [Internet]."},{"key":"10.1016\/j.bone.2025.117494_bb0120","unstructured":"Greenberg RN, Tice AD, Marsh PK, Craven PC, Reilly PM, Bollinger M, Weinandt WJ. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis. Am. J. Med. [Internet]. 82(4A). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/3555046\/."},{"issue":"5","key":"10.1016\/j.bone.2025.117494_bb0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"(OVIVA) Li HK","year":"2019","journal-title":"New England J. Med. [Internet]"},{"issue":"9","key":"10.1016\/j.bone.2025.117494_bb0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin. Infect. Dis. [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int. J. Infect. Dis. [Internet]"},{"issue":"9","key":"10.1016\/j.bone.2025.117494_bb0140","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cmi.2023.05.008","article-title":"Early switch from intravenous to oral antibiotic treatment in bone and joint infections","volume":"29","author":"Sendi","year":"2023","journal-title":"Clin. Microbiol. Infect. [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2025.117494_bb0145","article-title":"Risk factors associated with infection recurrence of posttraumatic osteomyelitis treated with Ilizarov bone transport technique\u2014a retrospective study of 149 cases","volume":"22","author":"Yalikun","year":"2021","journal-title":"BMC Musculoskelet. Disord. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2025.117494_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jor.24956","article-title":"The limitations of mono- and combination antibiotic therapies on immature biofilms in a murine model of implant-associated osteomyelitis","volume":"39","author":"Tomizawa","year":"2020","journal-title":"J. Orthop. Res.\u00ae [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2025.117494_bb0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijantimicag.2013.02.018","article-title":"In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections","volume":"41","author":"Molina-Manso","year":"2013","journal-title":"Int. J. Antimicrob. Agents [Internet]"},{"issue":"6","key":"10.1016\/j.bone.2025.117494_bb0160","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ajpath.2020.02.007","article-title":"Current concepts of osteomyelitis","volume":"190","author":"Hofstee","year":"2020","journal-title":"Am. J. Pathol. [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2025.117494_bb0165","article-title":"Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis","volume":"10","author":"Zelmer","year":"2022","journal-title":"Bone Res. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2025.117494_bb0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/10600280221101105","article-title":"Evaluation of opportunities for oral antibiotic therapy in bone and joint infections","volume":"57","author":"Bhagat","year":"2022","journal-title":"Ann. Pharmacother. [Internet]"},{"issue":"11","key":"10.1016\/j.bone.2025.117494_bb0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2106\/JBJS.19.00846","article-title":"The use and adverse effects of oral and intravenous antibiotic administration for suspected infection after revision shoulder arthroplasty","volume":"102","author":"Yao","year":"2020","journal-title":"J. Bone Joint Surg. [Internet]"},{"issue":"5","key":"10.1016\/j.bone.2025.117494_bb0180","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2106\/JBJS.16.00240","article-title":"Global forum: the burden of bone and joint infections","volume":"99","author":"Malizos","year":"2017","journal-title":"J. Bone Joint Surg. [Internet]"},{"issue":"247","key":"10.1016\/j.bone.2025.117494_bb0185","first-page":"356","article-title":"Health care costs of post-traumatic osteomyelitis in China: current situation and influencing factors","author":"Jiang","year":"2019","journal-title":"J. Surg. Res. [Internet]"},{"issue":"9","key":"10.1016\/j.bone.2025.117494_bb0190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/diacare.23.9.1333","article-title":"A cost analysis of diabetic lower-extremity ulcers","volume":"23","author":"Harrington","year":"2000","journal-title":"Diab. Care [Internet]"},{"issue":"10","key":"10.1016\/j.bone.2025.117494_bb0195","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/bmjqs-2015-004160","article-title":"The quadruple aim: care, health, cost and meaning in work","volume":"24","author":"Sikka","year":"2015","journal-title":"BMJ Qual. Saf. [Internet]"},{"issue":"1","key":"10.1016\/j.bone.2025.117494_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmi.2018.04.031","article-title":"Patient-related determinants of antibiotic use: a systematic review","volume":"25","author":"Zanichelli","year":"2018","journal-title":"Clin. Microbiol. Infect. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2025.117494_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/cid\/ciad196","article-title":"Intravenous to oral antibiotic switch therapy among patients hospitalized with Community-Acquired Pneumonia","volume":"77","author":"Deshpande","year":"2023","journal-title":"Clin. Infect. Dis. [Internet]"},{"key":"10.1016\/j.bone.2025.117494_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.12688\/wellcomeopenres.15314.4","article-title":"Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial","volume":"4","author":"McMeekin","year":"2020","journal-title":"Wellcome Open Res. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2025.117494_bb0215","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/AAC.02032-13","article-title":"Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Valour","year":"2013","journal-title":"Antimicrob. Agents Chemother. [Internet]"},{"issue":"5","key":"10.1016\/j.bone.2025.117494_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jinf.2013.07.017","article-title":"Epidemiology of adverse events and Clostridium difficile-associated diarrhea during long-term antibiotic therapy for osteoarticular infections","volume":"67","author":"Schindler","year":"2013","journal-title":"J. Infect. [Internet]"},{"issue":"3","key":"10.1016\/j.bone.2025.117494_bb0225","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijantimicag.2018.04.007","article-title":"Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review","volume":"52","author":"Lavergne","year":"2018","journal-title":"Int. J. Antimicrob. Agents [Internet]"},{"issue":"5","key":"10.1016\/j.bone.2025.117494_bb0230","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijantimicag.2017.08.011","article-title":"Explicit definitions of potentially inappropriate prescriptions of antibiotics in older patients: a compilation derived from a systematic review","volume":"50","author":"Baclet","year":"2017","journal-title":"Int. J. Antimicrob. Agents [Internet]"},{"issue":"12","key":"10.1016\/j.bone.2025.117494_bb0235","article-title":"Antibiotics for treating chronic osteomyelitis in adults","volume":"2013","author":"Conterno","year":"2013","journal-title":"Cochrane Library [Internet]"},{"issue":"2 Suppl","key":"10.1016\/j.bone.2025.117494_bb0240","first-page":"258","article-title":"Systemic antibiotic treatment of chronic osteomyelitis in adults","volume":"23","author":"Fantoni","year":"2019","journal-title":"PubMed [Internet]."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:30:41Z","timestamp":1746495041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"alternative-id":["S8756328225001061"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117494","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral versus intravenous antibiotics for bone and joint infections: Systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117494"}}